Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 153236)

Published in Infect Immun on May 01, 2003

Authors

Paul S Hoffman1, Neeraj Vats, Donna Hutchison, Jared Butler, Kenneth Chisholm, Gary Sisson, Ausra Raudonikiene, Jean S Marshall, Sander J O Veldhuyzen van Zanten

Author Affiliations

1: Department of Microbiology and Immunology, Division of Infectious Diseases, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. phoffman@tupdean2.med.dal.ca

Articles citing this

Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73

Use of genome-wide expression profiling and mutagenesis to study the intestinal lifestyle of Campylobacter jejuni. Infect Immun (2005) 1.62

The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol (2006) 1.55

Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun (2007) 1.39

Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35

Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun (2004) 1.21

Antisense RNA modulation of alkyl hydroperoxide reductase levels in Helicobacter pylori correlates with organic peroxide toxicity but not infectivity. J Bacteriol (2007) 1.16

Molecular chaperones in pathogen virulence: emerging new targets for therapy. Cell Host Microbe (2008) 1.14

Motility of urease-deficient derivatives of Helicobacter pylori. J Bacteriol (2004) 1.14

Diverse phenotypes resulting from polyphosphate kinase gene (ppk1) inactivation in different strains of Helicobacter pylori. J Bacteriol (2005) 1.11

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun (2006) 0.93

Dual control of Helicobacter pylori heat shock gene transcription by HspR and HrcA. J Bacteriol (2004) 0.91

Age-dependent changes in susceptibility of suckling mice to individual strains of Helicobacter pylori. Infect Immun (2005) 0.87

Helicobacter pylori possesses four coiled-coil-rich proteins that form extended filamentous structures and control cell shape and motility. J Bacteriol (2011) 0.86

Localization of FtsZ in Helicobacter pylori and consequences for cell division. J Bacteriol (2013) 0.82

Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects. Infect Immun (2013) 0.82

Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. Antimicrob Agents Chemother (2014) 0.79

Coiled coil rich proteins (Ccrp) influence molecular pathogenicity of Helicobacter pylori. PLoS One (2015) 0.77

Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during Colonization. J Immunol (2017) 0.75

Early Molecular Events in Murine Gastric Epithelial Cells Mediated by Helicobacter pylori CagA. Helicobacter (2016) 0.75

Instrumental Role of Helicobacter pylori γ-Glutamyl Transpeptidase in VacA-Dependent Vacuolation in Gastric Epithelial Cells. PLoS One (2015) 0.75

Articles cited by this

The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58

Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69

Helicobacter pylori. Clin Microbiol Rev (1997) 9.22

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72

Helicobacter pylori virulence and genetic geography. Science (1999) 7.64

Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol (1999) 4.72

Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun (1989) 3.81

Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene (1990) 3.67

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol (1998) 3.44

Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol (1993) 3.39

Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J Bacteriol (2001) 2.63

A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation. Mol Gen Genet (1998) 2.50

Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat Immunol (2001) 2.34

Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun (1990) 1.88

Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization. J Bacteriol (2001) 1.85

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol (2002) 1.68

Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol (1996) 1.64

Microbial molecular chaperones. Adv Microb Physiol (2001) 1.62

Reduced activation of inflammatory responses in host cells by mouse-adapted Helicobacter pylory isolates. Cell Microbiol (2002) 1.55

Acidic pH changes receptor binding specificity of Helicobacter pylori: a binary adhesion model in which surface heat shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect Immun (1996) 1.49

Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637. Antimicrob Agents Chemother (1999) 1.48

Dynamics of Helicobacter pylori colonization in relation to the host response. Proc Natl Acad Sci U S A (1999) 1.47

Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets. Infect Immun (1995) 1.43

Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. Mol Microbiol (1994) 1.41

Switching of flagellar motility in Helicobacter pylori by reversible length variation of a short homopolymeric sequence repeat in fliP, a gene encoding a basal body protein. Infect Immun (2000) 1.39

Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect Immun (2002) 1.37

Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun (2001) 1.33

Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28

Helicobacter pylori factors associated with disease. Gastroenterology (1999) 1.25

Colonization of germ-free transgenic mice with genotyped Helicobacter pylori strains from a case-control study of gastric cancer reveals a correlation between host responses and HsdS components of type I restriction-modification systems. J Biol Chem (2002) 1.24

The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter (2002) 1.23

Characterization of an acidic-pH-inducible stress protein (hsp70), a putative sulfatide binding adhesin, from Helicobacter pylori. Infect Immun (1998) 1.19

The autoregulatory HspR repressor protein governs chaperone gene transcription in Helicobacter pylori. Mol Microbiol (1999) 1.16

Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol (2000) 1.13

Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice. Proc Natl Acad Sci U S A (2002) 1.07

Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice. Infect Immun (1996) 1.03

Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice. Infect Immun (2002) 1.02

The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett (2001) 0.98

Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol (1999) 0.98

Surface-associated heat shock proteins of Legionella pneumophila and Helicobacter pylori: roles in pathogenesis and immunity. Infect Dis Obstet Gynecol (1999) 0.97

Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency. Microbiology (2002) 0.96

Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun (2000) 0.95

Mucosal chemokines in Helicobacter pylori infection. J Physiol Pharmacol (1997) 0.92

In vitro selection of high affinity HspR-binding sites within the genome of Helicobacter pylori. Gene (2002) 0.88

Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing. Aliment Pharmacol Ther (1999) 0.88

Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice. Toxicol Appl Pharmacol (1997) 0.86

Seropositivity to Helicobacter pylori heat shock protein 60 is strongly associated with intensity of chronic inflammation, particularly in antrum mucosa: an extension of an 18-year follow-up study of chronic gastritis in Saaremaa, Estonia. FEMS Immunol Med Microbiol (2001) 0.82

Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model. Antimicrob Agents Chemother (2002) 0.79

Articles by these authors

Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol (2006) 3.02

Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA (2008) 2.89

Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog (2011) 2.74

Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58

New and emerging roles for mast cells in host defence. Curr Opin Immunol (2006) 1.88

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.84

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol (2003) 1.71

The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem (2004) 1.58

The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol (2006) 1.55

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother (2006) 1.42

Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation. Int Arch Allergy Immunol (2010) 1.40

Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol (2004) 1.13

Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 1.12

IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol (2004) 1.10

A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol (2010) 1.10

Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol (2006) 1.07

Flavodoxin:quinone reductase (FqrB): a redox partner of pyruvate:ferredoxin oxidoreductase that reversibly couples pyruvate oxidation to NADPH production in Helicobacter pylori and Campylobacter jejuni. J Bacteriol (2007) 1.07

Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood (2008) 1.03

Global transcriptional analysis of acid-inducible genes in Streptococcus mutans: multiple two-component systems involved in acid adaptation. Microbiology (2009) 1.03

Dengue virus infection of mast cells triggers endothelial cell activation. J Virol (2010) 1.02

Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol (2006) 1.01

Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol (2010) 0.98

An inducible tellurite-resistance operon in Proteus mirabilis. Microbiology (2003) 0.97

Proteomic analysis of Candida albicans yeast and hyphal cell wall and associated proteins. Proteomics (2006) 0.97

Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology (2008) 0.95

A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol (2006) 0.95

RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS One (2012) 0.95

Quantitative proteomic investigation employing stable isotope labeling by peptide dimethylation on proteins of strawberry fruit at different ripening stages. J Proteomics (2013) 0.95

Additive attenuation of virulence and cariogenic potential of Streptococcus mutans by simultaneous inactivation of the ComCDE quorum-sensing system and HK/RR11 two-component regulatory system. Microbiology (2008) 0.92

A letter from CMAJ's editorial board to the CMA. CMAJ (2002) 0.90

TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cell degranulation. J Biol Chem (2008) 0.89

Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada. Can J Gastroenterol (2012) 0.89

Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis. J Leukoc Biol (2008) 0.89

Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. J Leukoc Biol (2008) 0.89

Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands. FASEB J (2011) 0.87

The appropriateness of surveillance colonoscopy intervals after polypectomy. Can J Gastroenterol (2013) 0.86

Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect Immun (2003) 0.85

Protein profiling in potato (Solanum tuberosum L.) leaf tissues by differential centrifugation. J Proteome Res (2012) 0.85

Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1). J Clin Microbiol (2002) 0.85

Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response. Cell Cycle (2015) 0.85

MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer. Cancer Res (2013) 0.83

Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses. Dev Comp Immunol (2010) 0.83

Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am J Pathol (2010) 0.81

Mast cells and IgE activation do not alter the development of oral tolerance in a murine model. J Allergy Clin Immunol (2012) 0.81

The gut microbiota of toll-like receptor 2-deficient mice exhibits lineage-specific modifications. Environ Microbiol Rep (2009) 0.80

Human mast cells induce caspase-independent DNA fragmentation in leukemic T cells. Oncol Rep (2003) 0.80

Predictors of interleukin-33 and thymic stromal lymphopoietin levels in cord blood. Pediatr Allergy Immunol (2015) 0.80

Local and systemic immunological parameters associated with remission of asthma symptoms in children. Allergy Asthma Clin Immunol (2012) 0.79

Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice. Immunobiology (2008) 0.79

Human mast cell activation with viruses and pathogen products. Methods Mol Biol (2015) 0.75

Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions. J Innate Immun (2016) 0.75

Air Pollution During Pregnancy and Cord Blood Immune System Biomarkers. J Occup Environ Med (2016) 0.75

Rapid testing of infection and disease states: the faster the better. Analyst (2007) 0.75

Keystone symposium on 'Mast cells, Basophils and IgE: host defense and disease'. Expert Rev Clin Immunol (2007) 0.75